We could not exclude the possibility that TJP1 amplification or expression is correlated with the response rate to immune checkpoint blockade; however, this is the first study to evaluate the TJP1 genetic alterations in bladder cancer patients. Here, TJP1 is linked to urinary bladder carcinoma.